ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies acting to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback